This Horizon Europe / EU Cancer Mission topic funds projects developing validated microbiome tools to predict transition to cancer before symptoms appear, with a focus on prevention and early detection.
The expected outcomes include microbiome tests/programmes for people at risk, earlier treatment initiation with higher success rates, and stronger evidence for prevention policy and strategic cancer programmes.
The call is currently open for submission under the EU Funding & Tenders Portal.
Eligibility Criteria:
- This topic is part of Horizon Europe, and applications are submitted through the EU Funding & Tenders Portal.
- Under Horizon Europe, legal entities from the EU and associated countries can participate; the programme is built for collaborative research and innovation.
- The portal states that grants are awarded to eligible third-party beneficiaries such as research organisations, public entities, NGOs, and private companies.
- Topic-specific admissibility and eligibility conditions are governed by the Horizon Europe call rules and General Annex B.
Funding Details:
- Budget: €15,000,000.
- Type of action: HORIZON Research and Innovation Actions (RIA).
- Call identifier: HORIZON-MISS-2026-02.
Deadline:
- Opening date: 10 February 2026.
- Deadline: 15 September 2026.
- Status: Open for submission.
Where to go for further information:
- Official topic details: Horizon Europe topic page
- Official EU call landing page: EU Funding & Tenders Portal – HORIZON-MISS-2026-02